Bill C-13, the COVID-19 Emergency Response Act, was the Canadian government’s legislative response to the Coronavirus pandemic. In addition a host of economic measures, the bill included some unexpected patent law provisions designed to speed access to essential medicines, devices or treatments. Matthew Herder, the director of the Health Law Institute at Dalhousie University, joins the podcast discuss the new Canadian rules, the use of compulsory licensing to enhance access to medicines, and other innovative approaches to overcoming potential access barriers raised by intellectual property laws.
Recent Posts
The Law Bytes Podcast, Episode 111: The Story Behind JusTech – How Three University of Ottawa Law Students Created a Technology Compliance Solution for Privacy Breach Rules 
The Law Bytes Podcast, Episode 110: Waiting to Connect – Karen Barnes and Catherine Middleton on the CCA’s Report on Internet Access in Canadian Rural, Remote and Indigenous Communities 
The Law Bytes Podcast, Episode 109: Striking the Balance on Misinformation and Freedom of Expression – My Examination of Canadian Policy Solutions 
The Law Bytes Podcast, Episode 108: Scott Benzie on How Bill C-10 Ignored Canada’s Thriving Digital First Creators 
The Law Bytes Podcast, Episode 107: Addison Cameron-Huff on the State of Crypto and Blockchain Regulation in Canada
